Company profile
Henry Meds
Henry Meds provides a telehealth platform for weight-management and other care programs. It describes consultation with healthcare providers, program-specific medication arrangements and support for cancellation through its patient portal.
henrymeds.com (opens in a new tab)Source-based assessment
What the evidence shows
Current terms explain billing and refund restrictions. Published program pricing is older, and no dispensing pharmacy is named in the assessed sources; pharmacy relationships are not inferred.
Benchmark score
22% of criteria assessed · Checked
Sources and evidence dates are listed below.
Limited evidencePharmacy license unverified
This score covers the assessed criteria only. Read it alongside the evidence coverage, unverified findings and any documented concerns below. A high score with limited coverage does not establish a complete assessment or a verified pharmacy license.
The same criteria measure verifiable operating disclosures and registry evidence. They do not establish medical safety, product purity or clinical outcomes.
The published terms identify Adonis Health, Inc. as the contracting platform operator and distinguish independent medical providers and pharmacies. The official site provides customer support contacts.
Named operator, an attributed physical business address and a working-purpose contact telephone. Distinguish registered or correspondence offices from clinical and dispensing locations; online care does not require a walk-in clinic. Weight: 8%.
The service describes healthcare-provider assessment and prescription fulfillment; individual credentials were not checked.
Who the service is for, prescribing or research-use boundaries, and provider information. Weight: 5%.
The program page lists charges and included items but is dated December 2025; a current individualized quote may differ.
Public prices or a defined quotation process, with recurring or additional charges explained. Weight: 5%.
The terms describe renewal and cancellation, prescription final-sale restrictions, and refund deductions: a $30 consultation fee after a prescription is issued and a possible processing fee. Approval of a refund is conditional.
Accessible cancellation, refund or ordering terms and a support channel. Weight: 4%.
Supply-chain evidence has not been sufficiently assessed.
Named dispensing partners for care services; analytical documentation or manufacturing information for research businesses. Weight: 10%.
An entity-specific regulatory assessment has not been completed. No clean record or adverse finding is inferred.
Entity/product-specific regulatory notices, enforcement, recalls and their resolution, with dates and jurisdiction. A pharmacy license match alone is not a regulatory-history review. No clean record is inferred from silence. Weight: 10%.
This criterion has not yet been established from the reviewed evidence.
Product- and lot-specific laboratory reports covering molecule identity and purity, with the laboratory, report date and issuer authenticity check. Full credit requires independently established laboratory identity and a traceable verified report. A testing policy or a report for another batch provides limited evidence only; purity does not establish sterility, endotoxin control or treatment safety. Weight: 12%.
This criterion has not yet been established from the reviewed evidence.
An applicable external accreditation, such as LegitScript for healthcare, matched to the exact business or domain in the issuer’s records. A badge alone does not establish current certification. Weight: 3%.
This criterion has not yet been established from the reviewed evidence.
Accessible privacy terms identifying the responsible entities, data uses and applicable health-data notice. A HIPAA claim is not independent verification of compliance; HIPAA is not required of every research business. Weight: 6%.
This criterion has not yet been established from the reviewed evidence.
Specific, dated evidence of relevant security practices or an independently issued audit, with its entity, scope and limits. HTTPS, a marketing seal or a claim of being unhackable is insufficient. Weight: 6%.
This criterion has not yet been established from the reviewed evidence.
Disclosed payment processing, billing authorization and recurring-charge arrangements. No processor brand is preferred and a processor does not certify the provider’s clinical or product quality. Weight: 3%.
This criterion has not yet been established from the reviewed evidence.
Clear product identity and intended use, distinguishing branded medicines, compounded preparations and research materials; presentation and preparation requirements where relevant. A compounded product is not assumed to be an approved generic. Weight: 8%.
This criterion has not yet been established from the reviewed evidence.
Product-specific delivery, temperature and storage instructions, including handling of shipping problems. Refrigeration, freezing or a particular presentation receives no automatic quality bonus. Weight: 5%.
No dispensing pharmacy and active state-license match has been verified.
At least one exactly named dispensing partner matched to an active, unreplaced official state record. This does not verify all partners or all jurisdictions. Weight: 15%.
Pharmacy & provider checks
Dispensing pharmacy not verified.
No dispensing pharmacy and active state-license match has been verified.
A closer look
What has been tested?
A laboratory report describes a particular sample. Check the product, lot, date and tests before applying it to another medication or shipment.
No independently authenticated lot report in this assessment
A product-specific report has not been established from the reviewed public evidence.
Identity, purity, potency, sterility and endotoxins are separate tests. A report does not establish clinical suitability or certify every batch supplied by a provider.
Go a little deeper
Your questions, organized.
Explore a detailed report of Henry Meds’s evidence, costs and open questions.
Community experiences
Customer reviews
No customer reviews yet. These opinions are separate from the editorial benchmark and do not change its score.
Email verification confirms account access, not a purchase or the accuracy of an opinion. Review guidelines
